Core Concept: In the wake of COVID-19, decentralized clinical trials move to center stage [Medical Sciences]
In January 2021, New York’s Northwell Health hospital system launched a clinical trial to learn whether the over-the-counter drug famotidine (also known as Pepcid) reduces the severity of COVID-19 in symptomatic patients who do not require hospitalization. The randomized trial began in response to anecdotal reports along with clinical studies...
Source: Proceedings of the National Academy of Sciences - Category: Science Authors: Marcus A. Banks Tags: Core Concepts, Medical Sciences, Front Matter, Coronavirus Related Source Type: research
More News: Academies | Clinical Trials | Coronavirus | COVID-19 | Famotidine | Hospitals | Learning | Science | Study | Universities & Medical Training